Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
29 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/29/3090260/0/en/Septerna-to-Present-at-Jefferies-Global-Healthcare-Conference.html
14 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-strikes-22-billion-deal-with-septerna-develop-new-obesity-2025-05-14/
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050481/0/en/Septerna-Provides-Corporate-Overview-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032857/0/en/Septerna-to-Present-at-TD-Cowen-45th-Annual-Health-Care-Conference.html
19 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/18/3027803/0/en/Septerna-Announces-Discontinuation-of-SEP-786-Phase-1-Clinical-Trial-and-Plans-to-Advance-Next-Generation-Oral-Small-Molecule-PTH1R-Agonist.html
06 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/06/3004454/0/en/Septerna-Expands-Leadership-with-Appointment-of-Industry-Veteran-Gil-Labrucherie-as-Chief-Financial-Officer.html
ABOUT THIS PAGE